Gastroenterology

Gastroenterology

Volume 135, Issue 3, September 2008, Pages 724-728
Gastroenterology

Mini-Reviews and Perspectives
Pancreatic Cancer Development and Progression: Remodeling the Model

https://doi.org/10.1053/j.gastro.2008.07.033Get rights and content

Section snippets

What Is the Best Evidence for the Linear Progression Model?

The study of human tissue samples is necessarily a snapshot of tumor progression. Therefore, establishment of phylogenetic relationships is possible only when a genetic event that occurs with a low frequency and displays individual tumor specificity is present in lesions representative of various tumor developmental stages. Even then, the relationship between the tumor and the preneoplastic lesions present nearby is questionable.

The increasing prevalence of a given molecular alteration with

Senescence: A Mechanism for Tumor Suppression

In the past few years, cellular senescence has been recognized as a process of permanent cell cycle exit in response to several types of stress, including oxidative stress, DNA damage, oncogenic stress, chemotherapeutic drugs, and telomere attrition.16 Senescence has emerged as a protective mechanism against tumor progression. The first evidence of a cellular checkpoint triggered by exogenous oncogene expression came from the observation that primary mouse embryo fibroblasts undergo senescence

Conclusion

The genetic evidence on the progression model of PDAC has been accepted widely as linear. However, there are alternative interpretations, especially in light of knowledge about OIS in vitro and in vivo. It may be time to revisit the current model of PDAC development and progression. The major impact of improved knowledge about PDAC progression will be a better appreciation of precursor lesions that evolve to PDAC and identification of patients at increased risk for PDAC.

First page preview

First page preview
Click to open first page preview

References (33)

  • R. Stoehr et al.

    Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer

    Eur Urol

    (2005)
  • R.H. Hruban et al.

    Progression model for pancreatic cancer

    Clin Cancer Res

    (2000)
  • A. Maitra et al.

    Pancreatic cancer

    Annu Rev Pathol Mech Dis

    (2008)
  • A.L. Cubilla et al.

    Morphological lesions associated with human primary invasive nonendocrine pancreatic cancer

    Cancer Res

    (1976)
  • L. Zhang et al.

    Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma

    Am J Surg Pathol

    (2007)
  • J. Luttges et al.

    Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution

    Virchows Arch

    (1999)
  • Cited by (0)

    Work in the authors' laboratory is supported, in part, by grants from the Ministerio de Educación y Ciencia (SAF2007-60860 and Consolider ONCOBIO) and European Union Biomed Programme (QLG-CY-2002-01196) and grant MolDiag-PaCa from the VIth Framework Programme.

    View full text